cTRL Therapeutics
PrivateLast Round
Early Funding
Oct 10, 2024
Total Funding Raised
$10M
Company Overview
cTRL Therapeutics is a biotechnology company specializing in microfluidic cell therapy that aims to treat cancerous tumors by utilizing proprietary cell-sorting technology to isolate and extract viable, tumor-reactive lymphocytes from blood for the development of non-invasive and efficient cancer treatments.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
cTRL Therapeutics Comps
Public and private peers based on sector, stage, and business model.
cTRL Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Oct 10, 2024 | ||||
| Seed | Apr 10, 2023 |
cTRL Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| General Catalyst | Seed |
| FACIT | Seed, Early Funding |
cTRL Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about cTRL Therapeutics's valuation, stock price, and market status.
